Correspondence | Published:

Reply to Comment on “Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy”

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    De Giorgi, V., Scarfì, F., Gori, A., Topa, A., Trane, L., & Portelli, F., et al. Comment on “Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy”. Br. J. Cancer. (2019) https://doi.org/10.1038/s41416-019-0430-9.

  2. 2.

    Santos, I. P., van Doorn, R., Caspers, P. J., Bakker Schut, T. C., Barroso, E. M. & Nijsten, T. E. C. et al. Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy. Br. J. Cancer 119, 1339–1346 (2018).

  3. 3.

    Kittler, H., Pehamberger, H., Wolff, K. & Binder, M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 3, 159–165 (2002).

  4. 4.

    Chen, S. C., Bravata, D. M., Weil, E. & Olkin, I. A comparison of dermatologists’ and primary care physicians’ accuracy in diagnosing melanoma: a systematic review. Arch. Dermatol. 137, 1627–1634 (2001).

  5. 5.

    Morton, C. A. & Mackie, R. M. Clinical accuracy of the diagnosis ofcutaneous malignant melanoma. Br. J. Cancer 138, 283–287 (1998).

Download references

Author information

Correspondence to Gerwin J. Puppels.

Ethics declarations

Competing interests

The authors declare no competing interests.

Note

This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark